Ixazomib Maintenance Study in Patients With AL Amyloidosis

NCT03618537 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Ixazomib
DRUG: Dexamethasone

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]